rs200805455
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP6
The NM_001369.3(DNAH5):c.6551T>C(p.Val2184Ala) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000115 in 1,613,846 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001369.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNAH5 | ENST00000265104.5 | c.6551T>C | p.Val2184Ala | missense_variant | Exon 39 of 79 | 1 | NM_001369.3 | ENSP00000265104.4 | ||
DNAH5 | ENST00000681290.1 | c.6506T>C | p.Val2169Ala | missense_variant | Exon 39 of 79 | ENSP00000505288.1 | ||||
DNAH5 | ENST00000683090.1 | n.1482T>C | non_coding_transcript_exon_variant | Exon 4 of 7 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152202Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000716 AC: 18AN: 251354Hom.: 0 AF XY: 0.0000589 AC XY: 8AN XY: 135844
GnomAD4 exome AF: 0.000123 AC: 180AN: 1461644Hom.: 0 Cov.: 31 AF XY: 0.000114 AC XY: 83AN XY: 727140
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152202Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74362
ClinVar
Submissions by phenotype
Primary ciliary dyskinesia Uncertain:2Benign:1
- -
- -
The p.V2184A variant (also known as c.6551T>C), located in coding exon 39 of the DNAH5 gene, results from a T to C substitution at nucleotide position 6551. The valine at codon 2184 is replaced by alanine, an amino acid with similar properties. This variant was previously reported in the SNPDatabase as rs200805455. Based on data from the NHLBI Exome Sequencing Project (ESP), the C allele has an overall frequency of approximately 0.01% (1/13006) total alleles studied and 0.01% (1/8600) European American alleles. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this variant remains unclear. -
not provided Benign:1
The DNAH5 p.Val2184Ala variant was not identified in the literature nor was it identified in Cosmic or LOVD 3.0. The variant was identified in dbSNP (ID: rs200805455) and ClinVar (classified as a VUS by Invitae). The variant was identified in control databases in 19 of 282754 chromosomes at a frequency of 0.000067 (Genome Aggregation Database March 6, 2019, v2.1.1). The variant was also observed in the European (non-Finnish) population in 19 of 129082 chromosomes (freq: 0.000147), but was not observed in the African, Latino, Ashkenazi Jewish, East Asian, European (Finnish), Other, or South Asian populations. The p.Val2184 residue is conserved in mammals and computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) provide inconsistent predictions regarding the impact to the protein; this information is not very predictive of pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at